| Detected | Trial | Change |
|---|---|---|
| 2026-05-30 | NCT05888233 Allopurinol Improves Heart Function in African Americans With Resistant Hypertension |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-05-30 | NCT05888233 Allopurinol Improves Heart Function in African Americans With Resistant Hypertension |
Enrollment reduced: 50 -> 40 participants |
| 2026-05-30 | NCT05888233 Allopurinol Improves Heart Function in African Americans With Resistant Hypertension |
date change Completion pushed: 2026-05-31 -> 2026-07-01 |
| 2026-05-21 | NCT07089888 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout |
Trial sites expanded: 83 -> 86 locations |
| 2026-05-14 | NCT07089888 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout |
Trial sites expanded: 78 -> 83 locations |
| 2026-05-14 | NCT07089875 A Study of Dotinurad Versus Allopurinol in Participants With Gout |
Trial sites expanded: 95 -> 100 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07089888 | A Study of Dotinurad Versus Allopurinol in Tophaceous Gout | Tophaceous Gout | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT07089875 | A Study of Dotinurad Versus Allopurinol in Participants With Gout | Gout | Recruiting |
| Phase 2/3 | |||
| NCT07574060 | Allopurinol in Depression | Depression | Not Yet Recruiting |
| Phase 2 | |||
| NCT05536349 | Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for… | Leukemia | Recruiting |
| NCT05888233 | Allopurinol Improves Heart Function in African Americans With Resistant Hypertension | Heart Failure Preserved Ejection Fraction | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT04026776 | Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm | Salt; Excess | Recruiting |